Skip to main content
letter
. 2018 Jun 14;6:21. doi: 10.1186/s40364-018-0134-y

Table 1.

Patient characteristics

Patients (n = 122) Controls (n = 58)
Age (years) 62 (37–86) 62 (43–81)
Sex (female) 60 (49%) 31 (53%)
ISS stage
 I 33 (27%)
 II 47 (39%)
 III 28 (23%)
 Unknown 14 (11%)
M-component
 IgG 75 (61%)
 IgA 29 (24%)
 Light chain 6 (5%)
 Unknown 12 (10%)
Skeletal affection
 None 12 (10%)
 Limited 49 (40%)
 Osteoporosis 9 (7%)
 Advanced 48 (39%)
 Unknown 4 (3%)